| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Nov 21, 2025 | Grant(A) | 106K | — | — | 106K |
| Nov 21, 2025 | Grant(A) | 44K | — | — | 44K |
| Nov 21, 2025 | Disposed to issuer(D) | 44K | — | — | 0 |
| Nov 21, 2025 | Grant(A) | 625K | — | $0 | 625K |
| Nov 21, 2025 | Disposed to issuer(D) | 106K | — | — | 0 |
| Nov 21, 2025 | Disposed to issuer(D) | 15K | — | — | 0 |
| Nov 21, 2025 | Disposed to issuer(D) | 25K | — | — | 0 |
| Nov 21, 2025 | Grant(A) | 35K | — | — | 35K |
| Nov 21, 2025 | Disposed to issuer(D) | 35K | — | — | 0 |
| Nov 21, 2025 | Grant(A) | 15K | — | — | 15K |
| Nov 21, 2025 | Grant(A) | 25K | — | — | 25K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-297205) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Xilio Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.